LUMINOUS study shows diversity in practice patterns, overall encouraging results

COPENHAGEN — Registry data from the recently concluded LUMINOUS study, a real-life observational study on the long-term safety, effectiveness, treatment patterns and quality-of-life outcomes related to the use of Lucentis, were shown and discussed by Paolo Lanzetta, MD, at the Euretina meeting.The study enrolled more than 30,000 patients in 40 countries from different continents and gathered information on retinal vascular diseases, including age-related macular degeneration, diabetic macular edema, retinal vein occlusion and myopic choroidal neovascularization.